相关实验视频

Updated: May 12, 2026

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

对结核病相关的血细胞性淋巴细胞结核病的全面见解:一个系统性审查

Arvin Eslami^1,2,3, Shaya Alimoghadam^1,2,3, Sanaz Khodadadi^1,2,3

¹Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

BMC infectious diseases

|November 24, 2024

概括

结合抗结核病治疗与血细胞淋巴细胞细胞瘤 (HLH) 特定疗法,特别是IVIG,可以改善结核病-HLH患者的生存率. 老年和并发症增加死亡风险.

科学领域:

传染性疾病传染性疾病
血液学血液学血液学
免疫学免疫学免疫学

背景情况:

结核病相关的血淋巴细胞淋巴菌细胞瘤 (TB-HLH) 由于结核病 (TB) 和HLH之间的复杂相互作用,提出了诊断和治疗方面的挑战.
这一系统性审查提供了全面的洞察力,结核病-HLH的流行病学,临床特征和治疗结果.

研究的目的:

系统地审查和分析有关TB-HLH的现有文献.
确定影响患者结果的关键因素,并评估治疗策略.

主要方法:

按照PRISMA指南进行了系统审查,搜索主要数据库,截至2023年5月16日.
包括病例报告和结核病和HLH患者的病例系列,记录了治疗结果.
使用统计分析,包括后勤回归来确定风险因素和治疗疗效.

主要成果:

分析了185篇涉及213名患者的文章,总死亡率为39%.
增加死亡率的独立风险因素包括年龄≥44岁和并发症 (p=0.005).
与HLH特异性疗法 (尤其是IVIG) 结合的抗结核治疗 (ATT) 与单独使用ATT相比,显著降低了死亡率 (p<0.05).

结论:

将ATT与HLH特定疗法 (包括IVIG) 结合起来,可显著提高结核病-HLH患者的存活率.
年龄≥44岁和并发症是关键的死亡风险因素.
早期怀疑和标准化治疗策略至关重要,特别是在结核病负担较高的地区.

关键词:

HLHH HLHH 这是一个很好的例子.血细胞性淋巴细胞细胞分裂.静脉注射的免疫球蛋白是一种免疫球蛋白.这是TB-HLHH.结核病是一种疾病.

更多相关视频

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...